Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
John Groopman
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Disorders
Living Beings
Concepts & Ideas
Procedures
Anatomy
Geographic Areas
Physiology
Sign-in to see full Profile
Network (preview)
67
Kensler, Thomas
27
Egner, Patricia
22
Roebuck, Bill
14
Qian, Geng-Sun
14
Scholl, Peter
13
Kuang, Shuang-Yuan
12
Muñoz, Alvaro
12
Wang, Jin-Bing
10
Zhu, Yuan-Rong
9
Friesen, Marlin
9
Wild, Christopher
9
Zarba, A
8
Zhang, Bao-Chu
8
Wang, Jia-Sheng
8
Sutter, Thomas
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of John Groopman (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Roebuck Bill D; Johnson Denise N; Sutter Carrie Hayes; Egner Patricia A; Scholl Peter F; Friesen Marlin D; Baumgartner Karen J; Ware Nicholas M; Bodreddigari Sridevi; Groopman John D; Kensler Thomas W; Sutter Thomas R
Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat.
Toxicological sciences : an official journal of the Society of Toxicology 2009;109(1):41-9.
-
2009: Yuan Jian-Min; Ambinder Alex; Fan Yunhua; Gao Yu-Tang; Yu Mimi C; Groopman John D
Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, China.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(2):590-4.
-
2008: Egner Patricia A; Kensler Thomas W; Chen Jian-Guo; Gange Stephen J; Groopman John D; Friesen Marlin D
Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry.
Chemical research in toxicology 2008;21(10):1991-6.
-
2008: Liby Karen; Yore Mark M; Roebuck Bill D; Baumgartner Karen J; Honda Tadashi; Sundararajan Chitra; Yoshizawa Hidenori; Gribble Gordon W; Williams Charlotte R; Risingsong Renee; Royce Darlene B; Dinkova-Kostova Albena T; Stephenson Katherine K; Egner Patricia A; Yates Melinda S; Groopman John D; Kensler Thomas W; Sporn Michael B
A novel acetylenic tricyclic bis-(cyano enone) potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxin.
Cancer research 2008;68(16):6727-33.
-
2008: Bransfield Leslie A; Rennie Alissa; Visvanathan Kala; Odwin Shelly-Ann; Kensler Thomas W; Yager James D; Friesen Marlin D; Groopman John D
Formation of two novel estrogen guanine adducts and HPLC/MS detection of 4-hydroxyestradiol-N7-guanine in human urine.
Chemical research in toxicology 2008;21(8):1622-30.
-
2008: McCoy Leslie F; Scholl Peter F; Sutcliffe Anne E; Kieszak Stephanie M; Powers Carissa D; Rogers Helen S; Gong Yun Yun; Groopman John D; Wild Christopher P; Schleicher Rosemary L
Human aflatoxin albumin adducts quantitatively compared by ELISA, HPLC with fluorescence detection, and HPLC with isotope dilution mass spectrometry.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(7):1653-7.
-
2008: Scholl Peter F; Groopman John D
Long-term stability of human aflatoxin B1 albumin adducts assessed by isotope dilution mass spectrometry and high-performance liquid chromatography-fluorescence.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(6):1436-9.
-
2008: Bodreddigari Sridevi; Jones Laundette Knight; Egner Patricia A; Groopman John D; Sutter Carrie Hayes; Roebuck Bill D; Guengerich F Peter; Kensler Thomas W; Sutter Thomas R
Protection against aflatoxin B1-induced cytotoxicity by expression of the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human AKR7A3.
Chemical research in toxicology 2008;21(5):1134-42.
-
2008: Johnson Denise N; Egner Patricia A; Obrian Greg; Glassbrook Norman; Roebuck Bill D; Sutter Thomas R; Payne Gary A; Kensler Thomas W; Groopman John D
Quantification of urinary aflatoxin B1 dialdehyde metabolites formed by aflatoxin aldehyde reductase using isotope dilution tandem mass spectrometry.
Chemical research in toxicology 2008;21(3):752-60.
-
2008: Groopman John D; Kensler Thomas W; Wild Christopher P
Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries.
Annual review of public health 2008;29():187-203.
-
2007: Chen Jian Guo; Kuang Shuang Yuan; Egner Patricia A; Lu Jian Hua; Zhu Yuan Rong; Wang Jin Bing; Zhang Bao Chu; Chen Tao Yang; Muñoz Alvaro; Kensler Thomas W; Groopman John D
Acceleration to death from liver cancer in people with hepatitis B viral mutations detected in plasma by mass spectrometry.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(6):1213-8.
-
2007: Simonich Michael T; Egner Patricia A; Roebuck Bill D; Orner Gayle A; Jubert Carole; Pereira Cliff; Groopman John D; Kensler Thomas W; Dashwood Roderick H; Williams David E; Bailey George S
Natural chlorophyll inhibits aflatoxin B1-induced multi-organ carcinogenesis in the rat.
Carcinogenesis 2007;28(6):1294-302.
-
2007: Everley Robert A; Ciner Frederic L; Zhan Dongliang; Scholl Peter F; Groopman John D; Croley Timothy R
Measurement of aflatoxin and aflatoxin metabolites in urine by liquid chromatography-tandem mass spectrometry.
Journal of analytical toxicology 2007;31(3):150-6.
-
2006: Egner Patricia A; Groopman John D; Wang Jia-Sheng; Kensler Thomas W; Friesen Marlin D
Quantification of aflatoxin-B1-N7-Guanine in human urine by high-performance liquid chromatography and isotope dilution tandem mass spectrometry.
Chemical research in toxicology 2006;19(9):1191-5.
-
2006: Skipper Paul L; Trudel Laura J; Kensler Thomas W; Groopman John D; Egner Patricia A; Liberman Rosa G; Wogan Gerald N; Tannenbaum Steven R
DNA adduct formation by 2,6-dimethyl-, 3,5-dimethyl-, and 3-ethylaniline in vivo in mice.
Chemical research in toxicology 2006;19(8):1086-90.
-
2006: Scholl Peter F; Turner Paul C; Sutcliffe Anne E; Sylla Abdoulaye; Diallo Momadou S; Friesen Marlin D; Groopman John D; Wild Christopher P
Quantitative comparison of aflatoxin B1 serum albumin adducts in humans by isotope dilution mass spectrometry and ELISA.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(4):823-6.
-
2006: Sapkota Amir; Halden Rolf U; Dominici Francesca; Groopman John D; Buckley Timothy J
Urinary biomarkers of 1,3-butadiene in environmental settings using liquid chromatography isotope dilution tandem mass spectrometry.
Chemico-biological interactions 2006;160(1):70-9.
-
2006: Yates Melinda S; Kwak Mi-Kyoung; Egner Patricia A; Groopman John D; Bodreddigari Sridevi; Sutter Thomas R; Baumgartner Karen J; Roebuck B D; Liby Karen T; Yore Mark M; Honda Tadashi; Gribble Gordon W; Sporn Michael B; Kensler Thomas W
Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole.
Cancer research 2006;66(4):2488-94.
-
2006: Scholl Peter F; McCoy Les; Kensler Thomas W; Groopman John D
Quantitative analysis and chronic dosimetry of the aflatoxin B1 plasma albumin adduct Lys-AFB1 in rats by isotope dilution mass spectrometry.
Chemical research in toxicology 2006;19(1):44-9.
-
2005: Lleonart Matilde E; Kirk Gregory D; Villar Stephanie; Lesi Olufunmilayo A; Dasgupta Abhijit; Goedert James J; Mendy Maimuna; Hollstein Monica C; Montesano Ruggero; Groopman John D; Hainaut Pierre; Friesen Marlin D
Quantitative analysis of plasma TP53 249Ser-mutated DNA by electrospray ionization mass spectrometry.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(12):2956-62.
-
2005: Kensler Thomas W; Chen Jian-Guo; Egner Patricia A; Fahey Jed W; Jacobson Lisa P; Stephenson Katherine K; Ye Lingxiang; Coady Jamie L; Wang Jin-Bing; Wu Yan; Sun Yan; Zhang Qi-Nan; Zhang Bao-Chu; Zhu Yuan-Rong; Qian Geng-Sun; Carmella Stephen G; Hecht Stephen S; Benning Lorie; Gange Stephen J; Groopman John D; Talalay Paul
Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(11 Pt 1):2605-13.
-
2005: Turner Paul C; Sylla Abdoulaye; Kuang Shuang-Yuan; Marchant Clare L; Diallo Mamadou S; Hall Andrew J; Groopman John D; Wild Christopher P
Absence of TP53 codon 249 mutations in young Guinean children with high aflatoxin exposure.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(8):2053-5.
-
2005: Groopman John D; Kensler Thomas W
Role of metabolism and viruses in aflatoxin-induced liver cancer.
Toxicology and applied pharmacology 2005;206(2):131-7.
-
2005: Kuang Shuang-Yuan; Lekawanvijit Suree; Maneekarn Niwat; Thongsawat Satawat; Brodovicz Kimberly; Nelson Kenrad; Groopman John D
Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(2):380-4.
-
2005: Groopman John D; Johnson Denise; Kensler Thomas W
Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk.
Cancer biomarkers : section A of Disease markers 2005;1(1):5-14.
-
2005: McCoy Leslie F; Scholl Peter F; Schleicher Rosemary L; Groopman John D; Powers Carissa D; Pfeiffer Christine M
Analysis of aflatoxin B1-lysine adduct in serum using isotope-dilution liquid chromatography/tandem mass spectrometry.
Rapid communications in mass spectrometry : RCM 2005;19(16):2203-10.
-
2004: Fox Mary A; Tran Nga L; Groopman John D; Burke Thomas A
Toxicological resources for cumulative risk: an example with hazardous air pollutants.
Regulatory toxicology and pharmacology : RTP 2004;40(3):305-11.
-
2004: Kensler Thomas W; Egner Patricia A; Wang Jin-Bing; Zhu Yuan-Rong; Zhang Bao-Chu; Lu Pei-Xin; Chen Jian-Guo; Qian Geng-Sun; Kuang Shuang-Yuan; Jackson Peta E; Gange Stephen J; Jacobson Lisa P; Muñoz Alvaro; Groopman John D
Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas.
Gastroenterology 2004;127(5 Suppl 1):S310-8.
-
2004: DeBord D Gayle; Savage Russell E; Drexler Hans; Freeman Caroline; Groopman John; Jayjock Michael; McDiarmid Melissa; Morgan Michael; Santella Regina; Schulte Paul; Talaska Glenn; Tardiff Robert; Viau Claude
A summary of the workshop applying biomarkers to occupational health practice.
Journal of occupational and environmental hygiene 2004;1(5):D57-60.
-
2004: Kuang Shuang-Yuan; Jackson Peta E; Wang Jin-Bing; Lu Pei-Xing; Muñoz Alvaro; Qian Geng-Sun; Kensler Thomas W; Groopman John D
Specific mutations of hepatitis B virus in plasma predict liver cancer development.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(10):3575-80.
-
2004: Vogel Arndt; van Den Berg Inge E T; Al-Dhalimy Muhsen; Groopman John; Ou Ching-Nan; Ryabinina Olga; Iordanov Mihail S; Finegold Milton; Grompe Markus
Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death.
Hepatology (Baltimore, Md.) 2004;39(2):433-43.
-
2004: Suk William A; Avakian Maureen D; Carpenter David; Groopman John D; Scammell Madeleine; Wild Christopher P
Human exposure monitoring and evaluation in the Arctic: the importance of understanding exposures to the development of public health policy.
Environmental health perspectives 2004;112(2):113-20.
-
2004: Lleonart Matilde E; Ramón y Cajal Santiago; Groopman John D; Friesen Marlin D
Sensitive and specific detection of K-ras mutations in colon tumors by short oligonucleotide mass analysis.
Nucleic acids research 2004;32(5):e53.
-
2003: Jackson Peta E; Kuang Shuang-Yuan; Wang Jin-Bing; Strickland Paul T; Muñoz Alvaro; Kensler Thomas W; Qian Geng-Sun; Groopman John D
Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients.
Carcinogenesis 2003;24(10):1657-63.
-
2003: Egner Patricia A; Yu Xiang; Johnson Jesse K; Nathasingh Christopher K; Groopman John D; Kensler Thomas W; Roebuck Bill D
Identification of aflatoxin M1-N7-guanine in liver and urine of tree shrews and rats following administration of aflatoxin B1.
Chemical research in toxicology 2003;16(9):1174-80.
-
2003: Kensler Thomas W; Qian Geng-Sun; Chen Jian-Guo; Groopman John D
Translational strategies for cancer prevention in liver.
Nature reviews. Cancer 2003;3(5):321-9.
-
2003: Patel Arti; Groopman John D; Umar Asad
DNA methylation as a cancer-specific biomarker: from molecules to populations.
Annals of the New York Academy of Sciences 2003;983():286-97.
-
2002: Heath Elisabeth I; DeWeese Theodore L; Partin Alan W; De Marzo Angelo M; Groopman John D; Nelson William G; Piantadosi Steven A; Lieberman Ron; Carducci Michael A
The design of a randomized, placebo-controlled trial of celecoxib in preprostatectomy men with clinically localized adenocarcinoma of the prostate.
Clinical prostate cancer 2002;1(3):182-7.
-
2002: Qian Geng-Sun; Kuang Shuang-Yuan; He Xia; Groopman John D; Jackson Peta E
Sensitivity of electrospray ionization mass spectrometry detection of codon 249 mutations in the p53 gene compared with RFLP.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(10 Pt 1):1126-9.
-
2002: Kensler Thomas W; Egner Patricia A; Wang Jin-Bing; Zhu Yuan-Rong; Zhang Bao-Chu; Qian Geng-Sun; Kuang Shuang-Yuan; Gange Stephen J; Jacobson Lisa P; Muñoz Alvaro; Groopman John D
Strategies for chemoprevention of liver cancer.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2002;11 Suppl 2():S58-64.
-
2001: Nelson W G; De Marzo A M; Deweese T L; Lin X; Brooks J D; Putzi M J; Nelson C P; Groopman J D; Kensler T W
Preneoplastic prostate lesions: an opportunity for prostate cancer prevention.
Annals of the New York Academy of Sciences 2001;952():135-44.
-
2001: Egner P A; Wang J B; Zhu Y R; Zhang B C; Wu Y; Zhang Q N; Qian G S; Kuang S Y; Gange S J; Jacobson L P; Helzlsouer K J; Bailey G S; Groopman J D; Kensler T W
Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(25):14601-6.
-
2001: Schwarz K B; Kew M; Klein A; Abrams R A; Sitzmann J; Jones L; Sharma S; Britton R S; Di Bisceglie A M; Groopman J
Increased hepatic oxidative DNA damage in patients with hepatocellular carcinoma.
Digestive diseases and sciences 2001;46(10):2173-8.
-
2001: Kwak M K; Egner P A; Dolan P M; Ramos-Gomez M; Groopman J D; Itoh K; Yamamoto M; Kensler T W
Role of phase 2 enzyme induction in chemoprotection by dithiolethiones.
Mutation research 2001;480-481():305-15.
-
2001: Walton M; Egner P; Scholl P F; Walker J; Kensler T W; Groopman J D
Liquid chromatography electrospray-mass spectrometry of urinary aflatoxin biomarkers: characterization and application to dosimetry and chemoprevention in rats.
Chemical research in toxicology 2001;14(7):919-26.
-
2001: Guengerich F P; Cai H; McMahon M; Hayes J D; Sutter T R; Groopman J D; Deng Z; Harris T M
Reduction of aflatoxin B1 dialdehyde by rat and human aldo-keto reductases.
Chemical research in toxicology 2001;14(6):727-37.
-
2001: Wang J S; Abubaker S; He X; Sun G; Strickland P T; Groopman J D
Development of aflatoxin B(1)-lysine adduct monoclonal antibody for human exposure studies.
Applied and environmental microbiology 2001;67(6):2712-7.
-
2001: Yoshikawa H; Matsubara K; Qian G S; Jackson P; Groopman J D; Manning J E; Harris C C; Herman J G
SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity.
Nature genetics 2001;28(1):29-35.
-
2001: Wang J S; Huang T; Su J; Liang F; Wei Z; Liang Y; Luo H; Kuang S Y; Qian G S; Sun G; He X; Kensler T W; Groopman J D
Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(2):143-6.
-
2001: Jackson P E; Qian G S; Friesen M D; Zhu Y R; Lu P; Wang J B; Wu Y; Kensler T W; Vogelstein B; Groopman J D
Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry.
Cancer research 2001;61(1):33-5.
-
2001: Nelson C P; Kidd L C; Sauvageot J; Isaacs W B; De Marzo A M; Groopman J D; Nelson W G; Kensler T W
Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1.
Cancer research 2001;61(1):103-9.
-
2001: Kensler T W; Davidson N E; Groopman J D; Muñoz A
Biomarkers and surrogacy: relevance to chemoprevention.
IARC scientific publications 2001;154():27-47.
-
2000: Stansbury K H; Noll D M; Groopman J D; Trush M A
Enzyme-mediated dialdehyde formation: an alternative pathway for benzo[a]pyrene 7,8-dihydrodiol bioactivation.
Chemical research in toxicology 2000;13(11):1174-80.
-
2000: Weaver V M; Buckley T; Groopman J D
Lack of specificity of trans,trans-muconic acid as a benzene biomarker after ingestion of sorbic acid-preserved foods.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(7):749-55.
-
2000: Jackson P E; Scholl P F; Groopman J D
Mass spectrometry for genotyping: an emerging tool for molecular medicine.
Molecular medicine today 2000;6(7):271-6.
-
2000: Li Y; Su J; Qin L; Egner P A; Wang J; Groopman J D; Kensler T W; Roebuck B D
Reduction of aflatoxin B(1) adduct biomarkers by oltipraz in the tree shrew (Tupaia belangeri chinensis).
Cancer letters 2000;154(1):79-83.
-
2000: Zavala A G; Lancaster T; Groopman J D; Strickland P T; Chandrasegaran S
Phage display of ScFv peptides recognizing the thymidine(6-4)thymidine photoproduct.
Nucleic acids research 2000;28(7):E24.
-
2000: Groopman J
Medicine on Mars.
New Yorker (New York, N.Y. : 1925) 2000;75(46):36-41.
-
2000: Carlson M A; Bargeron C B; Benson R C; Fraser A B; Phillips T E; Velky J T; Groopman J D; Strickland P T; Ko H W
An automated, handheld biosensor for aflatoxin.
Biosensors & bioelectronics 2000;14(10-11):841-8.
-
1999: Jackson P E; Groopman J D
Aflatoxin and liver cancer.
Baillière's best practice & research. Clinical gastroenterology 1999;13(4):545-55.
-
1999: Wang S S; O'Neill J P; Qian G S; Zhu Y R; Wang J B; Armenian H; Zarba A; Wang J S; Kensler T W; Cariello N F; Groopman J D; Swenberg J A
Elevated HPRT mutation frequencies in aflatoxin-exposed residents of daxin, Qidong county, People's Republic of China.
Carcinogenesis 1999;20(11):2181-4.
-
1999: Kinirons M T; O'Shea D; Kim R B; Groopman J D; Thummel K E; Wood A J; Wilkinson G R
Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A.
Clinical pharmacology and therapeutics 1999;66(3):224-31.
-
1999: Knight L P; Primiano T; Groopman J D; Kensler T W; Sutter T R
cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3.
Carcinogenesis 1999;20(7):1215-23.
-
1999: Rashid A; Wang J S; Qian G S; Lu B X; Hamilton S R; Groopman J D
Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
British journal of cancer 1999;80(1-2):59-66.
-
1999: Groisman I J; Koshy R; Henkler F; Groopman J D; Alaoui-Jamali M A
Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells.
Carcinogenesis 1999;20(3):479-83.
-
1999: Wang J S; Groopman J D
DNA damage by mycotoxins.
Mutation research 1999;424(1-2):167-81.
-
1999: Links J M; Kensler T W; Groopman J D
Biomarkers in environmental health research & practice.
Drug and chemical toxicology 1999;22(1):1-14.
-
1999: Wang J S; Shen X; He X; Zhu Y R; Zhang B C; Wang J B; Qian G S; Kuang S Y; Zarba A; Egner P A; Jacobson L P; Muñoz A; Helzlsouer K J; Groopman J D; Kensler T W
Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China.
Journal of the National Cancer Institute 1999;91(4):347-54.
-
1999: Kensler T W; Groopman J D; Sutter T R; Curphey T J; Roebuck B D
Development of cancer chemopreventive agents: oltipraz as a paradigm.
Chemical research in toxicology 1999;12(2):113-26.
-
1999: Groopman J D; Kensler T W
The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight?
Carcinogenesis 1999;20(1):1-11.
-
1999: Hoque A; Patt Y Z; Yoffe B; Groopman J D; Greenblatt M S; Zhang Y J; Santella R M
Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States?
Nutrition and cancer 1999;35(1):27-33.
-
1998: Laken S J; Jackson P E; Kinzler K W; Vogelstein B; Strickland P T; Groopman J D; Friesen M D
Genotyping by mass spectrometric analysis of short DNA fragments.
Nature biotechnology 1998;16(13):1352-6.
-
1998: DeWeese T L; Shipman J M; Larrier N A; Buckley N M; Kidd L R; Groopman J D; Cutler R G; te Riele H; Nelson W G
Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(20):11915-20.
-
1998: Kensler T W; Groopman J D; Roebuck B D
Use of aflatoxin adducts as intermediate endpoints to assess the efficacy of chemopreventive interventions in animals and man.
Mutation research 1998;402(1-2):165-72.
-
1998: Weaver V M; Buckley T J; Groopman J D
Approaches to environmental exposure assessment in children.
Environmental health perspectives 1998;106 Suppl 3():827-32.
-
1998: Landrigan P J; Carlson J E; Bearer C F; Cranmer J S; Bullard R D; Etzel R A; Groopman J; McLachlan J A; Perera F P; Reigart J R; Robison L; Schell L; Suk W A
Children's health and the environment: a new agenda for prevention research.
Environmental health perspectives 1998;106 Suppl 3():787-94.
-
1998: Groopman J
The destiny that lurks in our DNA.
Medical economics 1998;75(7):209-10, 213-6, 222 passim.
-
1997: Scholl P F; Musser S M; Groopman J D
Synthesis and characterization of aflatoxin B1 mercapturic acids and their identification in rat urine.
Chemical research in toxicology 1997;10(10):1144-51.
-
1997: Kensler T W; Gange S J; Egner P A; Dolan P M; Muñoz A; Groopman J D; Rogers A E; Roebuck B D
Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(8):603-10.
-
1997: Macé K; Aguilar F; Wang J S; Vautravers P; Gómez-Lechón M; Gonzalez F J; Groopman J; Harris C C; Pfeifer A M
Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines.
Carcinogenesis 1997;18(7):1291-7.
-
1997: Jacobson L P; Zhang B C; Zhu Y R; Wang J B; Wu Y; Zhang Q N; Yu L Y; Qian G S; Kuang S Y; Li Y F; Fang X; Zarba A; Chen B; Enger C; Davidson N E; Gorman M B; Gordon G B; Prochaska H J; Egner P A; Groopman J D; Muñoz A; Helzlsouer K J; Kensler T W
Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(4):257-65.
-
1997: Li Y; Yokoi T; Katsuki M; Wang J S; Groopman J D; Kamataki T
In vivo activation of aflatoxin B1 in C57BL/6N mice carrying a human fetus-specific CYP3A7 gene.
Cancer research 1997;57(4):641-5.
-
1997: Astier A; Avraham H; Manie S N; Groopman J; Canty T; Avraham S; Freedman A S
The related adhesion focal tyrosine kinase is tyrosine-phosphorylated after beta1-integrin stimulation in B cells and binds to p130cas.
The Journal of biological chemistry 1997;272(1):228-32.
-
1997: Zhang B C; Zhu Y R; Wang J B; Wu Y; Zhang Q N; Qian G S; Kuang S Y; Li Y F; Fang X; Yu L Y; De Flora S; Jacobson L P; Zarba A; Egner P A; He X; Wang J S; Chen B; Enger C L; Davidson N E; Gordon G B; Gorman M B; Prochaska H J; Groopman J D; Muñoz A; Kensler T W
Oltipraz chemoprevention trial in Qidong, Jiangsu Province, People's Republic of China.
Journal of cellular biochemistry. Supplement 1997;28-29():166-73.
-
1996: Scholl P; Musser S M; Kensler T W; Groopman J D
Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz.
Carcinogenesis 1996;17(6):1385-8.
-
1996: Soini Y; Chia S C; Bennett W P; Groopman J D; Wang J S; DeBenedetti V M; Cawley H; Welsh J A; Hansen C; Bergasa N V; Jones E A; DiBisceglie A M; Trivers G E; Sandoval C A; Calderon I E; Munoz Espinosa L E; Harris C C
An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.
Carcinogenesis 1996;17(5):1007-12.
-
1996: Weaver V M; Davoli C T; Heller P J; Fitzwilliam A; Peters H L; Sunyer J; Murphy S E; Goldstein G W; Groopman J D
Benzene exposure, assessed by urinary trans,trans-muconic acid, in urban children with elevated blood lead levels.
Environmental health perspectives 1996;104(3):318-23.
-
1996: Weaver V M; Davoli C T; Murphy S E; Sunyer J; Heller P J; Colosimo S G; Groopman J D
Environmental tobacco smoke exposure in inner-city children.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1996;5(2):135-7.
-
1996: Groopman J D; Wang J S; Scholl P
Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer.
Canadian journal of physiology and pharmacology 1996;74(2):203-9.
-
1996: Gange S J; Muñoz A; Wang J S; Groopman J D
Variability of molecular biomarker measurements from nonlinear calibration curves.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1996;5(1):57-61.
-
1996: Tritscher A M; Seacat A M; Yager J D; Groopman J D; Miller B D; Bell D; Sutter T R; Lucier G W
Increased oxidative DNA damage in livers of 2,3,7,8-tetrachlorodibenzo-p-dioxin treated intact but not ovariectomized rats.
Cancer letters 1996;98(2):219-25.
-
1996: Kensler T W; Groopman J D
Carcinogen-DNA and protein adducts: biomarkers for cohort selection and modifiable endpoints in chemoprevention trials.
Journal of cellular biochemistry. Supplement 1996;25():85-91.
-
1996: Kensler T W; Groopman J D; Wogan G N
Use of carcinogen-DNA and carcinogen-protein adduct biomarkers for cohort selection and as modifiable end points in chemoprevention trials.
IARC scientific publications 1996;(139):237-48.
-
1996: Groopman J D; Scholl P; Wang J S
Epidemiology of human aflatoxin exposures and their relationship to liver cancer.
Progress in clinical and biological research 1996;395():211-22.
-
1995: Groopman J D; Kensler T W; Links J M
Molecular epidemiology and human risk monitoring.
Toxicology letters 1995;82-83():763-9.
-
1995: Egner P A; Gange S J; Dolan P M; Groopman J D; Muñoz A; Kensler T W
Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz.
Carcinogenesis 1995;16(8):1769-73.
-
1995: Kang D H; Rothman N; Poirier M C; Greenberg A; Hsu C H; Schwartz B S; Baser M E; Groopman J D; Weston A; Strickland P T
Interindividual differences in the concentration of 1-hydroxypyrene-glucuronide in urine and polycyclic aromatic hydrocarbon-DNA adducts in peripheral white blood cells after charbroiled beef consumption.
Carcinogenesis 1995;16(5):1079-85.
-
1995: Strickland P T; Groopman J D
Biomarkers for assessing environmental exposure to carcinogens in the diet.
The American journal of clinical nutrition 1995;61(3 Suppl):710S-720S.
-
1995: Links J M; Kensler T W; Groopman J D
Biomarkers and mechanistic approaches in environmental epidemiology.
Annual review of public health 1995;16():83-103.
-
1995: Scholl P; Musser S M; Kensler T W; Groopman J D
Molecular biomarkers for aflatoxins and their application to human liver cancer.
Pharmacogenetics 1995;5 Spec No():S171-6.
-
1994: Weaver V M; Groopman J D
Fluorescence quantification of aflatoxin N7-guanine adducts.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1994;3(8):669-74.
-
1994: Rall D P; Groopman J D
Disease Prevention Research at NIH: An Agenda for All. Workshop C: The ambient environment--monitoring effects and initiating change.
Preventive medicine 1994;23(5):554-5.
-
1994: Bailey G S; Loveland P M; Pereira C; Pierce D; Hendricks J D; Groopman J D
Quantitative carcinogenesis and dosimetry in rainbow trout for aflatoxin B1 and aflatoxicol, two aflatoxins that form the same DNA adduct.
Mutation research 1994;313(1):25-38.
-
1994: Jakab G J; Hmieleski R R; Zarba A; Hemenway D R; Groopman J D
Respiratory aflatoxicosis: suppression of pulmonary and systemic host defenses in rats and mice.
Toxicology and applied pharmacology 1994;125(2):198-205.
-
1994: Groopman J D; Wogan G N; Roebuck B D; Kensler T W
Molecular biomarkers for aflatoxins and their application to human cancer prevention.
Cancer research 1994;54(7 Suppl):1907s-1911s.
-
1994: Strickland P T; Kang D; Bowman E D; Fitzwilliam A; Downing T E; Rothman N; Groopman J D; Weston A
Identification of 1-hydroxypyrene glucuronide as a major pyrene metabolite in human urine by synchronous fluorescence spectroscopy and gas chromatography-mass spectrometry.
Carcinogenesis 1994;15(3):483-7.
-
1994: Qian G S; Ross R K; Yu M C; Yuan J M; Gao Y T; Henderson B E; Wogan G N; Groopman J D
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1994;3(1):3-10.
-
1994: Groopman J D; Roebuck B D; Kensler T W
Carcinogen-DNA and protein adducts as intermediate biomarkers for human chemoprotection trials.
Advances in experimental medicine and biology 1994;354():149-60.
-
1993: Kinirons M T; O'Shea D; Downing T E; Fitzwilliam A T; Joellenbeck L; Groopman J D; Wilkinson G R; Wood A J
Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men.
Clinical pharmacology and therapeutics 1993;54(6):621-9.
-
1993: Rogers A E; Zeisel S H; Groopman J
Diet and carcinogenesis.
Carcinogenesis 1993;14(11):2205-17.
-
1993: Styczynski P B; Blackmon R C; Groopman J D; Kensler T W
The direct glucuronidation of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) by human and rabbit liver microsomes.
Chemical research in toxicology 1993;6(6):846-51.
-
1993: Groopman J D; Kensler T W
Molecular biomarkers for human chemical carcinogen exposures.
Chemical research in toxicology 1993;6(6):764-70.
-
1993: Bolton M G; Muñoz A; Jacobson L P; Groopman J D; Maxuitenko Y Y; Roebuck B D; Kensler T W
Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis.
Cancer research 1993;53(15):3499-504.
-
1993: Sheabar F Z; Groopman J D; Qian G S; Wogan G N
Quantitative analysis of aflatoxin-albumin adducts.
Carcinogenesis 1993;14(6):1203-8.
-
1993: Oleykowski C A; Mayernik J A; Lim S E; Groopman J D; Grossman L; Wogan G N; Yeung A T
Repair of aflatoxin B1 DNA adducts by the UvrABC endonuclease of Escherichia coli.
The Journal of biological chemistry 1993;268(11):7990-8002.
-
1993: Groopman J D; Wild C P; Hasler J; Junshi C; Wogan G N; Kensler T W
Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans.
Environmental health perspectives 1993;99():107-13.
-
1993: Kensler T W; Davidson N E; Groopman J D; Roebuck B D; Prochaska H J; Talalay P
Chemoprotection by inducers of electrophile detoxication enzymes.
Basic life sciences 1993;61():127-36.
-
1992: Guengerich F P; Shimada T; Raney K D; Yun C H; Meyer D J; Ketterer B; Harris T M; Groopman J D; Kadlubar F F
Elucidation of catalytic specificities of human cytochrome P450 and glutathione S-transferase enzymes and relevance to molecular epidemiology.
Environmental health perspectives 1992;98():75-80.
-
1992: Joellenbeck L; Qian Z; Zarba A; Groopman J D
Urinary 6 beta-hydroxycortisol/cortisol ratios measured by high-performance liquid chromatography for use as a biomarker for the human cytochrome P-450 3A4.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1992;1(7):567-72.
-
1992: Levy D D; Groopman J D; Lim S E; Seidman M M; Kraemer K H
Sequence specificity of aflatoxin B1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells.
Cancer research 1992;52(20):5668-73.
-
1992: Ross R K; Yu M C; Henderson B E; Yuan J M; Qian G S; Tu J T; Gao Y T; Wogan G N; Groopman J D
Aflatoxin biomarkers.
Lancet 1992;340(8811):119.
-
1992: Groopman J D; Skipper P L; Donahue P R; Trudel L J; Wildschutte M; Kadlubar F F; Tannenbaum S R
Monoclonal antibodies and rabbit antisera recognizing 4-aminobiphenyl--DNA adducts and application to immunoaffinity chromatography.
Carcinogenesis 1992;13(6):917-22.
-
1992: Zarba A; Hmieleski R; Hemenway D R; Jakab G J; Groopman J D
Aflatoxin B1--DNA adduct formation in rat liver following exposure by aerosol inhalation.
Carcinogenesis 1992;13(6):1031-3.
-
1992: Zarba A; Wild C P; Hall A J; Montesano R; Hudson G J; Groopman J D
Aflatoxin M1 in human breast milk from The Gambia, west Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC.
Carcinogenesis 1992;13(5):891-4.
-
1992: Ross R K; Yuan J M; Yu M C; Wogan G N; Qian G S; Tu J T; Groopman J D; Gao Y T; Henderson B E
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma.
Lancet 1992;339(8799):943-6.
-
1992: Raney K D; Shimada T; Kim D H; Groopman J D; Harris T M; Guengerich F P
Oxidation of aflatoxins and sterigmatocystin by human liver microsomes: significance of aflatoxin Q1 as a detoxication product of aflatoxin B1.
Chemical research in toxicology 1992;5(2):202-10.
-
1992: Wild C P; Hudson G J; Sabbioni G; Chapot B; Hall A J; Wogan G N; Whittle H; Montesano R; Groopman J D
Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1992;1(3):229-34.
-
1992: Groopman J D; Hall A J; Whittle H; Hudson G J; Wogan G N; Montesano R; Wild C P
Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1992;1(3):221-7.
-
1992: Groopman J D; DeMatos P; Egner P A; Love-Hunt A; Kensler T W
Molecular dosimetry of urinary aflatoxin-N7-guanine and serum aflatoxin-albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats.
Carcinogenesis 1992;13(1):101-6.
-
1992: Groopman J D; Hasler J A; Trudel L J; Pikul A; Donahue P R; Wogan G N
Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography.
Cancer research 1992;52(2):267-74.
-
1992: Groopman J D; Zhu J Q; Donahue P R; Pikul A; Zhang L S; Chen J S; Wogan G N
Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China.
Cancer research 1992;52(1):45-52.
-
1992: Kensler T W; Groopman J D; Eaton D L; Curphey T J; Roebuck B D
Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione.
Carcinogenesis 1992;13(1):95-100.
-
1992: Hudson G J; Wild C P; Zarba A; Groopman J D
Aflatoxins isolated by immunoaffinity chromatography from foods consumed in The Gambia, West Africa.
Natural toxins 1992;1(2):100-5.
-
1992: Groopman J D; Roebuck B D; Kensler T W
Molecular dosimetry of aflatoxin DNA adducts in humans and experimental rat models.
Progress in clinical and biological research 1992;374():139-55.
-
1992: Kensler T; Styczynski P; Groopman J; Helzlsouer K; Curphey T; Maxuitenko Y; Roebuck B D
Mechanisms of chemoprotection by oltipraz.
Journal of cellular biochemistry. Supplement 1992;16I():167-72.
-
1991: Puisieux A; Lim S; Groopman J; Ozturk M
Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens.
Cancer research 1991;51(22):6185-9.
-
1991: Huberman M; Bering H; Fallon B; Tessitore J; Sonnenborn H; Paul S; Zeffren J; Levitt D; Groopman J
A phase I study of an outpatient regimen of recombinant human interleukin-2 and alpha-2a-interferon in patients with solid tumors.
Cancer 1991;68(8):1708-13.
-
1991: Roebuck B D; Liu Y L; Rogers A E; Groopman J D; Kensler T W
Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry.
Cancer research 1991;51(20):5501-6.
-
1990: Neefe J R; Legha S S; Markowitz A; Salmon S; Meyskens F; Groopman J; Campion M; Evans L
Phase II study of recombinant alpha-interferon in malignant melanoma.
American journal of clinical oncology 1990;13(6):472-6.
-
1990: Sabbioni G; Ambs S; Wogan G N; Groopman J D
The aflatoxin-lysine adduct quantified by high-performance liquid chromatography from human serum albumin samples.
Carcinogenesis 1990;11(11):2063-6.
-
1990: Beaver R W; Wilson D M; James M A; Haydon K D; Colvin B M; Sangster L T; Pikul A H; Groopman J D
Distribution of aflatoxins in tissues of growing pigs fed an aflatoxin-contaminated diet amended with a high affinity aluminosilicate sorbent.
Veterinary and human toxicology 1990;32(1):16-8.
-
1990: Schrager T F; Newberne P M; Pikul A H; Groopman J D
Aflatoxin-DNA adduct formation in chronically dosed rats fed a choline-deficient diet.
Carcinogenesis 1990;11(1):177-80.
-
1990: Heagy W; Groopman J; Schindler J; Finberg R
Use of IFN-gamma in patients with AIDS.
Journal of acquired immune deficiency syndromes 1990;3(6):584-90.
-
1989: Russell A J; Trudel L J; Skipper P L; Groopman J D; Tannenbaum S R; Klibanov A M
Antibody-antigen binding in organic solvents.
Biochemical and biophysical research communications 1989;158(1):80-5.
-
1989: Koh H K; Prout M N; Groopman J D
Carcinogen monitoring by DNA adduct methodology in humans: clinical perspectives for the 1990s.
Advances in internal medicine 1989;34():243-64.
-
1988: Groopman J D; Donahue K F
Aflatoxin, a human carcinogen: determination in foods and biological samples by monoclonal antibody affinity chromatography.
Journal - Association of Official Analytical Chemists 1988;71(5):861-7.
-
1988: Foster P L; Groopman J D; Eisenstadt E
Induction of base substitution mutations by aflatoxin B1 is mucAB dependent in Escherichia coli.
Journal of bacteriology 1988;170(8):3415-20.
-
1988: Gan L S; Skipper P L; Peng X C; Groopman J D; Chen J S; Wogan G N; Tannenbaum S R
Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1.
Carcinogenesis 1988;9(7):1323-5.
-
1988: Liu Y L; Roebuck B D; Yager J D; Groopman J D; Kensler T W
Protection by 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) against the hepatotoxicity of aflatoxin B1 in the rat.
Toxicology and applied pharmacology 1988;93(3):442-51.
-
1988: Groopman J D
Do aflatoxin-DNA adduct measurements in humans provide accurate data for cancer risk assessment?
IARC scientific publications 1988;(89):55-62.
-
1988: Groopman J D; Cain L G; Kensler T W
Aflatoxin exposure in human populations: measurements and relationship to cancer.
Critical reviews in toxicology 1988;19(2):113-45.
-
1987: Mandal S; Ahuja A; Shivapurkar N M; Cheng S J; Groopman J D; Stoner G D
Inhibition of aflatoxin B1 mutagenesis in Salmonella typhimurium and DNA damage in cultured rat and human tracheobronchial tissues by ellagic acid.
Carcinogenesis 1987;8(11):1651-6.
-
1987: Kensler T W; Egner P A; Dolan P M; Groopman J D; Roebuck B D
Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
Cancer research 1987;47(16):4271-7.
-
1987: Groopman J D
DNA adducts of nitropyrene detected by specific antibodies.
Research report (Health Effects Institute) 1987;(7):1-17.
-
1987: Groopman J D; Kensler T W
The use of monoclonal antibody affinity columns for assessing DNA damage and repair following exposure to aflatoxin B1.
Pharmacology & therapeutics 1987;34(2):321-34.
-
1987: Groopman J D; Roebuck B D; Kensler T W
Application of monoclonal antibodies and dietary antioxidant-based animal models to define human exposure to aflatoxin B1.
Progress in experimental tumor research. Fortschritte der experimentellen Tumorforschung. Progrès de la recherche expérimentale des tumeurs 1987;31():52-62.
-
1986: Skipper P L; Bryant M S; Tannenbaum S R; Groopman J D
Analytical methods for assessing exposure to 4-aminobiphenyl based on protein adduct formation.
Journal of occupational medicine. : official publication of the Industrial Medical Association 1986;28(8):643-6.
-
1986: Kensler T W; Egner P A; Davidson N E; Roebuck B D; Pikul A; Groopman J D
Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases.
Cancer research 1986;46(8):3924-31.
-
1986: Harris C C; LaVeck G; Groopman J; Wilson V L; Mann D
Measurement of aflatoxin B1, its metabolites, and DNA adducts by synchronous fluorescence spectrophotometry.
Cancer research 1986;46(7):3249-53.
-
1986: Groopman J D
Application of monoclonal antibodies to monitor human exposure to aflatoxin B1.
Basic life sciences 1986;38():463-71.
-
1985: Groopman J D; Donahue P R; Zhu J Q; Chen J S; Wogan G N
Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(19):6492-6.
-
1985: Kensler T W; Egner P A; Trush M A; Bueding E; Groopman J D
Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione.
Carcinogenesis 1985;6(5):759-63.
-
1985: Wolff T; Distlerath L M; Worthington M T; Groopman J D; Hammons G J; Kadlubar F F; Prough R A; Martin M V; Guengerich F P
Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling.
Cancer research 1985;45(5):2116-22.
-
1985: Sarna G; Mitsuyasu R; Figlin R; Ambersley J; Groopman J
Oral vinzolidine as therapy for Kaposi's sarcoma and carcinomas of lung, breast, and colon/rectum.
Cancer chemotherapy and pharmacology 1985;14(1):12-4.
-
1984: Groopman J D; Trudel L J; Donahue P R; Marshak-Rothstein A; Wogan G N
High-affinity monoclonal antibodies for aflatoxins and their application to solid-phase immunoassays.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(24):7728-31.
-
1984: Merrill J E; Kutsunai S; Mohlstrom C; Hofman F; Groopman J; Golde D W
Proliferation of astroglia and oligodendroglia in response to human T cell-derived factors.
Science (New York, N.Y.) 1984;224(4656):1428-30.
-
1982: Groopman J D; Haugen A; Goodrich G R; Wogan G N; Harris C C
Quantitation of aflatoxin B1-modified DNA using monoclonal antibodies.
Cancer research 1982;42(8):3120-4.
-
1981: Groopman J D; Croy R G; Wogan G N
In vitro reactions of aflatoxin B1-adducted DNA.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(9):5445-9.
-
1981: Haugen A; Groopman J D; Hsu I C; Goodrich G R; Wogan G N; Harris C C
Monoclonal antibody to aflatoxin B1-modified DNA detected by enzyme immunoassay.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(7):4124-7.
-
1981: Groopman J D; Fowler K W; Busby W F; Wogan G N
Interaction of aflatoxin B2 with rat liver DNA and histones in vivo.
Carcinogenesis 1981;2(12):1371-3.
-
1980: Groopman J D; Busby W F; Wogan G N
Nuclear distribution of aflatoxin B1 and its interaction with histones in rat liver in vivo.
Cancer research 1980;40(12):4343-51.
Sign-in to see more